Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Fatigue and PDGFRA[original query] |
---|
The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study. BMC cancer 2012 12 (1): 107. Rutkowski Piotr, Bylina El?bieta, Klimczak Anna, Switaj Tomasz, Falkowski S?awomir, Kroc Jacek, Lugowska Iwona, Brzeskwiniewicz Magdalena, Melerowicz Wojciech, Osuch Czes?aw, Mierzejewska Ewa, Wasielewski Kacper, Wo?niak Agnieszka, Grzesiakowska Urszula, Nowecki Zbigniew I, Siedlecki Janusz A, Limon Janu |
A phase II study of a human anti-PDGFRa monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors. Annals of oncology : official journal of the European Society for Medical Oncology 2017 Mar 28 (3): 541-546. Wagner A J, Kindler H, Gelderblom H, Schöffski P, Bauer S, Hohenberger P, Kopp H-G, Lopez-Martin J A, Peeters M, Reichardt P, Qin A, Nippgen J, Ilaria R L, Rutkowski |
A Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 8 28 (1): 84-94. Singh Arun S, Hecht J Randolph, Rosen Lee, Wainberg Zev A, Wang Xiaoyan, Douek Michael, Hagopian Anahis, Andes Rachel, Sauer Lauren, Brackert Sandra R, Chow Warren, DeMatteo Ronald, Eilber Fritz Christian, Glaspy John A, Chmielowski Barto |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: